Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Abstract Text:

Post-translational modifications enable extra layers of control of the proteome, and perhaps the most important is proteolysis, a major irreversible modification affecting every protein. The intersection of the protease web with a proteome sculpts that proteome, dynamically modifying its state and function. Protease expression is distorted in cancer, so perturbing signaling pathways and the secretome of the tumor and reactive stromal cells. Indeed many cancer biomarkers are stable proteolytic fragments. It is crucial to determine which proteases contribute to the pathology versus their roles in homeostasis and in mitigating cancer. Thus the full substrate repertoire of a protease, termed the substrate degradome, must be deciphered to define protease function and to identify drug targets. Degradomics has been used to identify many substrates of matrix metalloproteinases that are important proteases in cancer. Here we review recent degradomics technologies that allow for the broadly applicable identification and quantification of proteases (the protease degradome) and their activity state, substrates, and interactors. Quantitative proteomics using stable isotope labeling, such as ICAT, isobaric tags for relative and absolute quantification (iTRAQ), and stable isotope labeling by amino acids in cell culture (SILAC), can reveal protease substrates by taking advantage of the natural compartmentalization of membrane proteins that are shed into the extracellular space. Identifying the actual cleavage sites in a complex proteome relies on positional proteomics and utilizes selection strategies to enrich for protease-generated neo-N termini of proteins. In so doing, important functional information is generated. Finally protease substrates and interactors can be identified by interactomics based on affinity purification of protease complexes using exosite scanning and inactive catalytic domain capture strategies followed by mass spectrometry analysis. At the global level, the N terminome analysis of whole communities of proteases in tissues and organs in vivo provides a full scale understanding of the protease web and the web-sculpted proteome, so defining metadegradomics.

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Molecular & cellular proteomics : MCP

VOLUME: 7

Page Numbers: 1925-51

Journal Abbreviation: Mol. Cell Proteomics

ISSN: 1535-9484

DAY: 2

MONTH: 07

YEAR: 2008

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101125647

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.

AFFILIATION: Centre for Blood Research, 4.401 Life Sciences Institute, University of British Columbia, 2350 Health Sciences Mall, Vancouver, British Columbia V6T 1Z3, Canada. adoucet@interchange.ubc.ca

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Mol Cell Proteomics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome Related Publications

• ACTH and cortisone in the treatment of atopic dermatitis.
• Analysis of Cortical Arrays from Tradescantia virginiana at High Resolution Reveals Discrete Microtubule Subpopulations and Demonstrates That Confocal Images of Arrays Can Be Misleading.
• Brief psychiatric rating scale for children: quantitative scoring of medical records.
• Clinical and virologic course of herpes simplex genitalis.
• Cytoskeletal thermal ratchets and cytoskeletal tensegrity: determinants of brain asymmetry and symmetry?
• Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases.
• Histology of spheroidal degeneration of the cornea in Labrador.
• Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective
• Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.
• Matrix Metalloproteinase Processing of CXCL11/I-TAC Results in Loss of Chemoattractant Activity and Altered Glycosaminoglycan Binding.
• Matrix metalloproteinases in periodontal tissue remodelling.
• Medical differentials with potential behavioral manifestations.
• Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.
• Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.
• Plant collagenase: unique collagenolytic activity of cysteine proteases from ginger.
• Potential role of tubulin acetylation and microtubule-based protein trafficking in familial dysautonomia.
• Protease research in the era of systems biology.
• Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites.
• Reflection across plant cell boundaries in confocal laser scanning microscopy.
• Research criteria for the diagnosis of depression.
• Strategies for identifying patterns of categorical variables that have diagnostic significance.
• The geographic distribution of the ACE II genotype: a novel finding.